NCT01512212

Brief Summary

Evaluation of the effectivity of the new thyroid fine needle aspiration biopsy (FNAB) apparatus of which patented from Turkish Patent Institute.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2012

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2012

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

January 10, 2012

Completed
9 days until next milestone

First Posted

Study publicly available on registry

January 19, 2012

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2012

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2012

Completed
Last Updated

January 19, 2012

Status Verified

January 1, 2012

Enrollment Period

5 months

First QC Date

January 10, 2012

Last Update Submit

January 13, 2012

Conditions

Thyroid Cancer

Keywords

thyroidfineneedleaspirationbiopsynewtechnique

Outcome Measures

Primary Outcomes (1)

  • number of cells

    number of aspirated cells will be compared

    2

Secondary Outcomes (1)

  • type of cells

    2

Study Arms (1)

single group

NO INTERVENTION

FNAB will be perform first with standart technique and after with new FNAB apparatus

Procedure: biopsy

Interventions

biopsyPROCEDURE

fnab

Also known as: fnab
single group

Eligibility Criteria

Age17 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • fine needle aspiration biopsy indicated noduler goiter patients

You may not qualify if:

  • diffuse goiter

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bezmialem Vakif University

Istanbul, Marmara, 34564, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Thyroid NeoplasmsThyroid Diseases

Interventions

Biopsy1-fluoro-2-nitro-4-azidobenzene

Condition Hierarchy (Ancestors)

Endocrine Gland NeoplasmsNeoplasms by SiteNeoplasmsHead and Neck NeoplasmsEndocrine System Diseases

Intervention Hierarchy (Ancestors)

CytodiagnosisCytological TechniquesClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisSpecimen HandlingDiagnostic Techniques, SurgicalSurgical Procedures, OperativeInvestigative Techniques

Study Officials

  • adnan yuksel, prof

    Bezmialem Vakif University

    STUDY CHAIR

Central Study Contacts

erhan aysan, prof

CONTACT

902122531700dr@webcerrah.com

adnan yuksel, prof

CONTACT

902124531701ayuksel@bezmialem.edu.tr

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD Prof.

Study Record Dates

First Submitted

January 10, 2012

First Posted

January 19, 2012

Study Start

January 1, 2012

Primary Completion

June 1, 2012

Study Completion

September 1, 2012

Last Updated

January 19, 2012

Record last verified: 2012-01

Locations

TU(1)